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Folic acid source, usual intake, and folate and vitamin B-12 status in US
adults: National Health and Nutrition Examination Survey (NHANES)
2003–2006
Abstract
Background: US adults have access to multiple sources of folic acid. The contribution of these sources to usual
intakes above the tolerable upper intake level (UL) (1000 ug/d) and to folate and vitamin B-12 status is
unknown. Objective: The objective was to estimate usual folic acid intake above the UL and adjusted serum
and red blood cell folate, vitamin B-12, methylmalonic acid, and homocysteine concentrations among US
adults by 3 major folic acid intake sources - enriched cereal-grain products (ECGP), ready-to-eat cereals
(RTE), and supplements (SUP) - categorized into 4 mutually exclusive consumption groups. Design: We used
data from the National Health and Nutrition Examination Survey (NHANES) 2003-2006 (n = 8258).
Results: Overall, 2.7% (95% CI: 1.9%, 3.5%) of adults consumed more than the UL of folic acid. The
proportions of those who consumed folic acid from ECGP only, ECGP+RTE, ECGP+SUP, and
ECGP+RTE+SUP were 42%, 18%, 25%, and 15%, respectively. Of 60% of adults who did not consume
supplements containing folic acid (ECGP only and ECGP+RTE), 0% had intakes that exceeded the UL. Of
34% and 6% of adults who consumed supplements with an average of <400 and>400 ug folic acid/d, <1% and
47.8% (95% CI: 39.6%, 56.0%), respectively, had intakes that exceeded the UL. Consumption of RTE and/or
supplements with folic acid was associated with higher folate and vitamin B-12 and lower homocysteine
concentrations, and consumption of supplements with vitamin B-12 was associated with lower
methylmalonic acid concentrations (P < 0.001). Conclusion: At current fortification levels, US adults who do
not consume supplements or who consume an average of <400 ug folic acid/d from supplements are unlikely
to exceed the UL in intake for folic acid.
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Folic acid source, usual intake, and folate and vitamin B-12 status
in US adults: National Health and Nutrition Examination Survey
(NHANES) 2003–20061–4
Quanhe Yang, Mary E Cogswell, Heather C Hamner, Alicia Carriquiry, Lynn B Bailey, Christine M Pfeiffer, and
Robert J Berry
ABSTRACT
Background: US adults have access to multiple sources of folic
acid. The contribution of these sources to usual intakes above the
tolerable upper intake level (UL) (1000 lg/d) and to folate and
vitamin B-12 status is unknown.
Objective: The objective was to estimate usual folic acid intake
above the UL and adjusted serum and red blood cell folate, vitamin
B-12, methylmalonic acid, and homocysteine concentrations among
US adults by 3 major folic acid intake sources—enriched cereal-
grain products (ECGP), ready-to-eat cereals (RTE), and supple-
ments (SUP)—categorized into 4 mutually exclusive consumption
groups.
Design: We used data from the National Health and Nutrition Ex-
amination Survey (NHANES) 2003–2006 (n = 8258).
Results: Overall, 2.7% (95% CI: 1.9%, 3.5%) of adults consumed
more than the UL of folic acid. The proportions of those who
consumed folic acid from ECGP only, ECGP+RTE, ECGP+SUP,
and ECGP+RTE+SUP were 42%, 18%, 25%, and 15%, respec-
tively. Of 60% of adults who did not consume supplements contain-
ing folic acid (ECGP only and ECGP+RTE), 0% had intakes that
exceeded the UL. Of 34% and 6% of adults who consumed supple-
ments with an average of 400 and .400 lg folic acid/d,,1% and
47.8% (95% CI: 39.6%, 56.0%), respectively, had intakes that ex-
ceeded the UL. Consumption of RTE and/or supplements with folic
acid was associated with higher folate and vitamin B-12 and lower
homocysteine concentrations, and consumption of supplements with
vitamin B-12 was associated with lower methylmalonic acid con-
centrations (P , 0.001).
Conclusion: At current fortification levels, US adults who do not
consume supplements or who consume an average of 400 lg folic
acid/d from supplements are unlikely to exceed the UL in intake for
folic acid. Am J Clin Nutr 2010;91:64–72.
INTRODUCTION
Rates of neural tube defects declined in conjunction with the
full implementation of fortification of enriched cereal-grain
products (ECGP) with 140 lg folic acid/100 g flour in the United
States in 1998 (1–5). Serum folate concentrations for all seg-
ments of the US population more than doubled between 1988–
1994 and 1999–2004 (6). This raised the question of whether or
not some subgroups might exceed the tolerable upper intake
level (UL) for folic acid, ie, 1000 lg/d for adults aged 19 y.
The UL, which is the highest usual intake level of a nutrient that
is likely to pose no risk of adverse effects in healthy persons,
was set by the Institute of Medicine to ensure that the diagnosis
of macrocytic anemia due to vitamin B-12 deficiency would not
be masked by excess intake of folate from fortified foods or
supplements (ie, folic acid) and lead to delays in treatment and
an increased risk of developing neurologic complications (7).
During the postfortification era, US adults can consume
multiple sources of folic acid, eg, ECGP, ready-to-eat cereals
(RTE), and supplements (SUP). The prevalence of US adults
whose usual intake exceeds the UL is unknown. Previous studies
used one 24-h dietary recall (8) or average data from multiple
dietary recalls (9), both of which can bias the estimate of the
proportion of adults who exceed 1000 lg/d (10, 11). One study
adjusted for within-individual variation in dietary intake, but
estimated total folate, rather than folic acid, intake (12). Data on
the associations of source of folic acid with folate and vitamin
B-12 status are limited to small nonrepresentative populations or
to intake of either dietary or supplement sources of folic acid,
but not both (9, 13–15). Results from a previous investigation in
US adults in 2001–2004 suggest that the average consumption of
folic acid from supplements and from RTE was positively and
strongly associated with quintiles of serum folate concentrations
(16). In the present study, we determined the proportions of the
US adults in 2003–2006 with usual intakes that exceeded the UL
and folate and vitamin B-12 status by source of folic acid intake.
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SUBJECTS AND METHODS
Study population
Data were obtained from the National Health and Nutrition
Examination Survey (NHANES), a stratified multistage proba-
bility survey designed to represent the civilian, noninstitu-
tionalized US population. Data for NHANES were collected by
the National Center for Health Statistics (NCHS) at the Centers
for Disease Control and Prevention (CDC) via household in-
terviews and physical examinations. Detailed information is
available elsewhere (17, 18). The survey was reviewed and ap-
proved by the NCHS ethics review board, and participants
provided written informed consent before participation. The
nonpregnant adult populations aged 19 y from NHANES
2003–2004 and 2005–2006 were selected for this evaluation
because the UL for daily folic acid intake is the same for all
nonpregnant adults (1000 lg/d) (7), and two 24-h dietary recalls
were available on survey participants (17, 18).
The overall unweighted examination response rates for adults
in NHANES 2003–2004 and 2005–2006 were 69% and 71%,
respectively, calculated as the number of examined adults divided
by the total number selected for the sample (19, 20). Of the
nonpregnant adults aged 19 y who attended the medical ex-
amination center (MEC) (n = 9478), we excluded 584 partic-
ipants with incomplete data on the first or second 24-h dietary
recall, ie, did not meet the minimum acceptable standards for
data quality. We then excluded 627 who were missing in-
formation on the second 24-h dietary recall such that we could
not code their consumption of RTE with folic acid (see below).
We excluded an additional 9 who were missing information on
use of supplements containing folic acid, which left 8258 par-
ticipants for analyses.
For the analyses of folate and vitamin B-12 status, we excluded
an additional 778 participants who were missing information on
serum folate, red blood cell (RBC) folate, or vitamin B-12
concentrations, which left 7480 adults. Finally, methylmalonic
acid (MMA) concentrations were not analyzed for NHANES
2005–2006; thus, we present results for MMA concentrations in
3638 participants in NHANES 2003–2004.
Intakes of folic acid, vitamin B-12, and natural food folate
Information on dietary intake of foods was obtained from two
24-h dietary recalls from NHANES 2003–2004 and 2005–2006.
Dietary intake data for day 1 was collected in person in the MEC,
and data for day 2 were obtained by telephone 3–10 d later. For
NHANES 2003–2004 and 2005–2006, the intake of nutrients [ie,
natural food folate, folic acid, and vitamin B-12 (vitamin B-12
includes intake from natural and synthetic sources)] from foods
was estimated by using the most current US Department of
Agriculture (USDA) Food and Nutrient Databases for Dietary
Studies (FNDDS version 2 and FNDDS version 3, respectively)
(21, 22). Estimates of folic acid intake are reported in micrograms
and were not converted to micrograms of Dietary Folate
Equivalents, which adjusts for the higher bioavailability of folic
acid than of natural food folate.
The individual food file for each 24-h dietary recall contains
the estimated nutrient consumption for every food reported by
every participant. From these files, we selected participants who
reported consumption of at least one food coded as an RTE (food
codes 57000000–57418000). For each of these participants, we
summed the amount of folic acid consumed from RTE in the
previous 24 h. A small percentage of participants (,2%) con-
sumed RTE that did not contain folic acid. Participants who
reported consumption of RTE that contained folic acid on either
day of the two 24-h dietary recalls were classified as consumers
of RTE with folic acid.
During the household interviews, participants were asked
about their use of dietary supplements during the past 30 d. For
each supplement, the participant was asked the number of days of
consumption and the quantity consumed per day. The interviewer
recorded the name of each product and matched it to a list. After
the survey, trained nutritionists obtained label information and
determined ingredients and serving size (ie, tablets or ounces per
dose). A participant was classified as a consumer of supplements
containing folic acid if he or she reported consuming any sup-
plement with folic acid during the past 30 d. For each individual,
the amount of nutrients was summed across all supplements with
folic acid consumed and divided by 30 to yield the average daily
amount of supplemental nutrients. The total nutrient intake on
each day was calculated as the amount of nutrients from foods
on that day plus the average daily amount of nutrients from
supplements.
Biochemical measurements of folate and vitamin B-12
status
Serum folate, RBC folate, and serum vitamin B-12 concen-
trations were measured by Quantaphase II radioassay (Bio-Rad
Laboratories, Hercules, CA). Long-term CVs for NHANES
2003–2006 were 4–7% for serum folate concentrations, 4–6% for
RBC folate concentrations, and 3–6% for serum vitamin B-12
concentrations (6). Plasma homocysteine concentrations were
measured by a fully automated fluorescence polarization im-
munoassay on the Abbott AxSym system (Abbott Laboratories,
Abbott Park, IL) from 2003 to 2006 (23, 24). Plasma MMA
concentrations were measured by gas chromatography–mass
spectrometry with cyclohexanol derivatization (23). We arbi-
trarily defined high serum folate concentration as .20 ng/mL
based on the highest calibration point in theBio-Rad assays before
protein diluent is needed, which was similar to the 95th percentile
for the US population before fortification, ie, 17 ng/mL (1). We
arbitrarily defined vitamin B-12 depletion as ,300 pg/mL. Not
considered to indicate deficiency, this threshold can indicate the
need for further investigation of vitamin B-12 deficiency with
MMA and homocysteine (7, 25).
Covariates
Questionnaire information included sex, age, race-ethnicity,
and smoking status. Race-ethnicity was reported by participants
based on a list that included an open-ended response. Non-
Hispanic blacks and Mexican Americans were oversampled in
NHANES. For analysis, race-ethnicity was categorized as non-
Hispanic white, non-Hispanic black, and Mexican American.
Sample sizes for other race-ethnicity groups were too small for
meaningful analysis. Smoking status was based on the response
to the following question: “Do you now smoke cigarettes?”
Height and weight were measured by using standard protocols
and calibrated equipment in the MEC. Body mass index (BMI)
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was calculated as weight (in kg) divided by height squared (in m).
Day of the week is the day of the week on which the 24-h dietary
recall was collected.
Statistical analyses
Adults were classified into 4 mutually exclusive folic acid
consumption groups: 1) fortified foods excluding RTE or sup-
plements (ECGP only), 2) ECGP plus RTE cereals excluding
supplements containing folic acid (ECGP+RTE), 3) ECGP
(excluding RTE) plus supplements containing folic acid (ECGP
+SUP), and 4) ECGP+RTE+SUP. Participants in groups 3 and 4
consumed supplements containing folic acid. Participants in
groups 2 and 4 consumed RTE with folic acid. Proportions and
95% CIs of US adults in each folic acid consumption group were
estimated overall and by sex, age, and race-ethnicity group.
Distributions [eg, medians and interquartile ranges (IQRs)] of
usual folic acid and vitamin B-12 intakes and the prevalence of
folic acid consumption .1000 lg/d overall and by folic acid
consumption group were estimated by using data on total usual
folic acid intake from both of the 24-h dietary recalls and
Software for Intake Distribution Estimation (PC-SIDE version
1.02, 2003; Department of Statistics, Iowa State University)
(26–28). Dietary data from a single 24-h dietary recall does not
represent usual intake because of the within individual day-to-
day variation in diet and may bias the estimates of the pro-
portion of individuals above or below a certain nutrient intake
level (10, 11). PC-SIDE requires that at least some of the re-
spondents have multiple days of nutrient values to estimate the
within- and between-individual variation (27). A small percent-
age (,1%) of participants with an initial 24-h dietary recall had
incomplete or no data on the second 24-h dietary recall and their
values on the second recall were considered “missing.” The usual
natural food folate intake was also estimated by folic acid con-
sumption groups and selected sociodemographic characteristics.
In PC-SIDE, all analyses were adjusted for age, sex, race-
ethnicity, interview method (in person or by phone), and day of
the week. SEs were estimated by using a set of 60 jackknife
repeated replication weights with PC-SIDE. Jackknife replication
weights were calculated by using a combination of dietary
weights based on the second 24-h dietary recall for most of the
participants, and dietary weights were based on the first 24-h
dietary recall for the few who did not have a second recall.
Multiple linear regression models were used to estimate the
geometric means (least-squares means) and 95% CIs for serum
and RBC folate, homocysteine, vitamin B-12, and MMA con-
centrations by folic acid consumption group adjusted for sex, age,
race-ethnicity, current smoking status, and BMI. Because the
distributions of these biomarkers were skewed, the natural log
was used. Satterthwaite-adjusted F tests were used to examine
the statistical significance of differences in the adjusted geo-
metric means. Adjusted relative differences (exponentiated b
coefficients) and 95% CIs are reported in the text.
Logistic regression was used to estimate the prevalences (ie,
predictive margins) and 95% CIs of high serum folate and vitamin
B-12 depletion adjusted for age, sex, race-ethnicity, current smoking
status, and BMI. Interactions of folic acid consumption group with
age, sex, and race-ethnicity group were tested from the differences
in the log-likelihood ratios and df for models with and without the
interactions terms in relation to the chi-square distribution.
Differences in the proportions of US adults in folic acid
consumption groups by sociodemographic characteristics and
prevalences of high serum folate and vitamin B-12 depletion by
folic acid consumption groups were evaluated with the chi-square
test. All tests were 2-tailed, a = 0.05. Sample weights were used
for all analyses to account for differential nonresponse and
noncoverage and to adjust for planned oversampling of some
groups. We analyzed all data except, usual intakes (for which we
used PC-SIDE as described previously), using SUDAAN sta-
tistical software (release 9.0; Research Triangle Institute, Re-
search Triangle Park, NC) to account for the complex sampling
design (29).
RESULTS
Among US adults, 42%, 18%, 25%, and 15% reported con-
sumption of folic acid from ECGP only, ECGP+RTE, ECGP
+SUP, and ECGP+RTE+SUP, respectively (Table 1). The pro-
portion of US adults in the 4 consumption groups differed by
sex, age, and race-ethnicity. Compared with women, a lower
proportion of men consumed folic acid from supplements
(36.2% compared with 43.0%; P , 0.001). Compared with
adults aged 19–39 y, a higher proportion aged 60 y consumed
folic acid from supplements (51.7% compared with 30.2%; P ,
0.001). Compared with non-Hispanic white adults, a lower
proportion of non-Hispanic black and Mexican American adults
consumed folic acid from more than one source (62.6%, 42.1%,
and with 41.7%, respectively; P , 0.001).
Usual intake of folic acid, vitamin B-12, and natural food
folate
The usual median intake of folic acid differed across folic acid
consumption groups (Table 2) (P , 0.0001). After adjustment
for measurement error, age, sex, race-ethnicity, interview
method (in person or by phone), and day of the week, usual
median intakes) of folic acid for ECGP only, ECGP+RTE,
ECGP+SUP, and ECGP+RTE+SUP were 138, 274, 479, and 635
lg/d, respectively. Differences across consumption groups in
usual median intakes were consistent within sex, age, and race-
ethnicity groups.
Adjusted usual median intakes of vitamin B-12 for ECGP only,
ECGP+RTE, ECGP+SUP, and ECGP+RTE+SUP were 4.3, 7.3,
15.7, and 18.6 lg/d, respectively (Table 2). Differences across
consumption groups were consistent within sex, age, and race-
ethnicity groups. Across folic acid consumption groups, adjusted
usual median intakes of natural food folate varied from 197,
205, and 208 to 212 lg/d, respectively. Average usual intake of
natural food folate differed slightly between supplements users
and nonusers (ECGP only and ECGP+RTE compared with.
ECGP+SUP and ECGP+RTE+SUP; P , 0.05) among the total
population, among women, and among adults aged 19–39 y,
but not among other sex, age, and race-ethnicity groups (see
Supplemental Table 1 under “Supplemental data” in the online
issue).
Of the total US adult population, an estimated 2.7% (95% CI:
1.9%, 3.5%) exceeded the UL for folic acid. Of the 60% of adults
who did not consume supplements containing folic acid (ECGP
only and ECGP+RTE), 0% exceeded the UL (Figure 1). Of the
adults who consumed ECGP+SUP and ECGP+RTE+SUP, 5.5%
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(95% CI: 3.0%, 8.0%) and 9.4% (95% CI: 5.5%, 13.3%) ex-
ceeded the UL, respectively. Except for men and adults aged
60 y, estimates of the proportion above the UL were statisti-
cally unreliable across consumption groups when stratified by
sex, age, and race-ethnicity and are not shown. Of any pop-
ulation subgroup, usual folic acid intakes of adults aged 60 y
who consumed ECGP+RTE+SUP were the most likely to ex-
ceed the UL (12.8%; 95% CI: 7.1%, 18.5%).
Because intake above the UL occurred only among supplement
users, we further examined average daily intake of folic acid from
supplements: 0, 1–200, 201–400, and .400 lg (Figure 2). The
estimated proportions of US adults in each group were 60.6%,
10.9%, 23.5%, and 5.9%, respectively. The median total folic
acid intakes in the 4 subgroups were 173, 316, 546, and 983 lg
folic acid/d, respectively. Less than 1% of adults who consumed
an average of 400 lg folic acid/d from supplements exceeded
the UL: 0.47% (95% CI: 0.02%, 0.91%) and 0.56% (95% CI:
0.27%, 0.85%) of adults who consumed 1–200 or 201–400 lg
folic acid/d from supplements, respectively, and 47.8% (95% CI:
39.5%, 56.0%) of adults who consumed an average of .400 lg
folic acid/d from supplements.
Serum and RBC folate, serum vitamin B-12, homocysteine,
and MMA concentrations
A significant dose-response relation was observed in serum
and RBC folate, vitamin B-12, and homocysteine concentrations
relative to the usual median intake of folic acid consumption
group. Compared with adults who consumed ECGP only, for
example, among those who consumed ECGP+RTE, ECGP+SUP,
and ECGP+RTE+SUP, the geometric mean serum folate con-
centrations were 25.3% (95% CI: 22.1%, 28.4%), 44.1% (95%
CI: 39.9%, 48.3%), and 80.0% (95% CI: 63.1%, 88.2%) higher,
respectively (Table 3). Compared with adults who consumed
ECGP only, geometric mean MMA concentrations did not differ
from those of adults who consumed ECGP+RTE (P . 0.05) but
were 10% lower in adults who consumed ECGP+SUP.
These relations appeared to be consistent and significant across
age, sex, and race-ethnicity groups, with the exception of serum
vitamin B-12 and MMA concentrations among Mexican
Americans and MMA concentrations among non-Hispanic black
adults and adults aged 19–39 y. The differences in these con-
centrations by folic acid consumption groups were not statisti-
cally significant (P . 0.05).
Prevalence of high serum folate and vitamin B-12 depletion
The absolute differences in the adjusted prevalence of high
serum folate concentration by folic acid consumption group were
modified by sex, age group, and race-ethnicity (P, 0.05), but the
prevalence ratios were similar across sociodemographic groups
(Table 4). Compared with adults who consumed ECGP only,
adults who consumed ECGP+RTE+SUP were ’10 times more
likely to have high serum folate concentrations and 70% less
likely to have vitamin B-12 depletion.
DISCUSSION
Since the initiation of fortification, ,3% of US adults have
exceeded the UL for folic acid. We estimated that nearly 60% of
US adults consumed folic acid from RTE and/or supplements
and 15% from both. Compared with the consumption of ECGP
only, regular consumption of RTE with folic acid was associated
with about a 100% higher usual intake, and use of supplements
with folic acid with about a 200% higher intake. Despite the
contributions to median folic acid intakes of ECGP, RTE, and
supplements, the 94% of US adults who do not consume sup-
plements or consume 400 lg folic acid/d from supplements
are unlikely to exceed the UL for folic acid.
TABLE 1
Proportion of US adults aged 19 y by folic acid consumption group and sociodemographic characteristics: National Health and Nutrition Examination
Survey (NHANES) 2003–20061
Source of folic acid exposure (95% CI)2
Characteristic Participants ECGP only ECGP+RTE ECGP+SUP ECGP+RTE+SUP
n %
Total 8258 42.2 (39.4, 45.1) 18.0 (16.7, 19.5) 25.2 (23.2, 27.3) 14.6 (13.2, 16.1)
Sex
Female 4115 40.2 (37.3, 43.1) 16.8 (15.2, 18.4) 27.2 (24.8, 29.8) 15.8 (14.2, 17.6)
Male 4143 44.4 (40.9, 47.9) 19.4 (17.2, 21.8) 23.0 (20.7, 25.5) 13.2 (11.6, 15.1)
Age
19–39 y 2932 48.2 (44.0, 52.5) 21.6 (19.4, 24.1) 18.6 (16.2, 21.3) 11.6 (9.7, 13.7)
40–59 y 2456 43.2 (40.0, 46.4) 15.1 (13.1, 17.4) 29.4 (26.4, 32.7) 12.3 (10.4, 14.6)
60 y 2870 31.4 (28.6, 34.3) 16.9 (14.8, 19.3) 29.0 (26.0, 32.2) 22.7 (20.3, 25.3)
Race-ethnicity group
Non-Hispanic white 4304 37.4 (33.4, 41.5) 18.3 (16.7, 20.0) 27.3 (24.8, 29.9) 17.1 (15.1, 19.2)
Non-Hispanic black 1763 57.9 (54.5, 61.2) 17.1 (14.6, 19.9) 18.3 (15.2, 21.9) 6.7 (5.3, 8.4)
Mexican American 1638 58.3 (53.1, 63.3) 19.9 (16.3, 24.2) 14.3 (11.0, 18.3) 7.6 (5.6, 10.2)
1 ECGP only, consumed enriched cereal-grain products only, excluding ready-to-eat cereals and supplements containing folic acid; ECGP+RTE,
consumed enriched cereal-grain products plus ready-to-eat cereals; ECGP+SUP, consumed enriched cereal-grain products (excluding ready-to-eat cereals)
plus supplements containing folic acid; ECGP+RTE+SUP, consumed enriched cereal-grain products, ready-to-eat cereals, and supplements containing folic
acid.
2 Percentages are weighted, and CIs take into account the complex sampling design.
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The median usual daily intake of folic acid among adults who
consumed ECGP only (138 lg) was slightly higher than the
Food and Drug Administration’s estimated range of 70 to 130
lg (2). Among adults who consumed ECGP only, higher usual
mean folic acid intakes occurred in men than in women,
in adults aged ,60 y than in those aged 60 y, and in non-
Hispanic whites than in non-Hispanic blacks (t tests, P , 0.01
for all). These associations are consistent with differences in the
estimated postfortification changes in folate intake from a pre-
vious study (12), but not with mean serum or RBC folate con-
centrations in the current study. This finding may be related to
differences across population subgroups in natural food folate
intake or folic acid metabolism.
Our results, in agreement with previous studies, indicate that
the consumption of RTE and/or supplements contributes sig-
nificantly to intakes of folic acid and that supplements or RTE are
associated with higher serum folate and/or lower homocysteine
concentrations (9, 13–15). Our study also indicates that the
consumption of RTE and/or supplements with folic acid is as-
sociated with higher usual vitamin B-12 intakes and concen-
trations among US adults. More than 95% of RTE and
supplement consumers also consumed vitamin B-12 from these
sources (data not shown).
The masking of vitamin B-12 deficiency is a concern among
older adults (6). Among US adults aged 60 y, a higher prev-
alence of high folate concentrations and a lower prevalence of
vitamin B-12 depletion were positively associated with intake of
RTE and/or supplements with folic acid. The estimated joint
prevalence of low vitamin B-12 status (defined as ,300 pg/mL)
and usual intake exceeding the UL of folic acid is 0.1% (95%
CI: 0.04%, 0.26%) among all US adults and 0.1% (95% CI:
0.01%, 0.71%) among US adults aged .60 y. These estimates
are statistically unreliable because of the small number of US
adults in our sample who both consumed .1000 lg folic acid
and had low vitamin B-12 concentrations (unweighted n = 11
adults, n = 3 adults aged . 60 y). Lower MMA concentrations
were associated with consumption of supplements with folic acid
(t test, P, 0.001 for differences in adjusted geometric means for
ECGP+SUP or ECGP+SUP+RTE compared with ECGP only),
but not RTE (t test, P = 0.116 for difference in adjusted geometric
means for ECGP+RTE compared with ECGP only). Because the
vast majority of RTE and supplements with folic acid also contain
vitamin B-12, consumption may reduce the risk of vitamin B-12
deficiency among older adults. As did another recent report (30),
our data suggest that US adults aged 60 y who do not consume
supplements with vitamin B-12 may be at increased risk of vita-
min B-12 deficiency, even those with median usual vitamin B-12
intakes of ’3 lg/d from RTE (greater than the Recommended
Dietary Allowance of 2.4 lg/d) (7).
The strengths of this study include its use of a large nationally
representative sample of US adults, its oversampling of pop-
ulation subgroups by age and race-ethnicity, its adjustment for
potential confounders, its use of folate and vitamin B-12 bio-
markers to evaluate dose response across groups, and its appli-
cation of an established statistical method by using two 24-h
dietary recalls in most of the sample to estimate usual folic acid
and vitamin B-12 intakes.
Potential limitations include the inability to examine temporal
associations due to the cross-sectional design of the survey.
Dietary data were self-reported and were collected at the time of
the medical examination or shortly thereafter, and supplement
data were collected over the 30 d before the survey, thus requiring
that we combined intake data obtained with the 2 different
instruments. The 24-h dietary recall underestimates calorie intake
by ’11% (31), but this does not indicate that micronutrient
intake is also underestimated by the same amount. Actual folic
acid and vitamin B-12 in foods may be higher or lower than that
estimated in the nutrient database. Average nutrient intakes from
supplements do not reflect irregular patterns of intake for some
individuals; therefore, the within-person variability in total folic
acid intake may be underestimated. The amount of folic acid and
FIGURE 1. The cumulative distribution of usual intake of folic acid for
US adults who consumed enriched cereal-grain products with folic acid
(ECGP) only [n = 3731; 0.0% exceeded the tolerable upper intake level
(UL); ……], ECGP plus ready-to-eat cereals with folic acid (RTE) (n =
1546; 0.0% exceeded the UL; _ . _), ECGP plus supplements with folic
acid (SUP) [n = 1894; 5.5% (95% CI: 3.0%, 8.0%) exceeded the UL; _ _ _],
or ECGP+RTE+SUP [n = 1087; 9.4% (95% CI: 5.5%, 13.3%) exceeded the
UL; ____].
FIGURE 2. The cumulative distribution of usual intake of folic acid for
US adults who consumed no supplements containing folic acid [n = 5277;
0.0% exceeded the tolerable upper intake level (UL); ……], an average of 1–
200 lg folic acid/d from supplements [n = 703; 0.47% (95% CI: 0.02%,
0.91%) exceeded the UL;. _ . _], an average of 201–400 lg folic acid/d from
supplements [n = 1776; 0.56% (95% CI: 0.27%, 0.85%) exceeded the UL;
_ _ _], or an average of .400 lg folic acid/d from supplements [n = 441;
47.8% (95% CI: 39.5%, 56.0%) exceeded the UL; ____].
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TABLE 3
Serum folate, red blood cell (RBC) folate, homocysteine, vitamin B-12, and methylmalonic acid concentrations by folic acid consumption group and by
sociodemographic characteristics among US adults aged 19 y: National Health and Nutrition Examination Survey (NHANES) 2003–20061
Adjusted geometric mean concentration (95% CIs)2
Folic acid consumption group Participants3 Serum folate RBC folate Homocysteine Serum vitamin B-12 Methylmalonic acid
n ng/mL ng/mL lmol/L pg/mL lmol/L
Total
ECGP only 3337 (1653) 9.4 (9.2, 9.6) 234 (230, 239) 8.8 (8.6, 8.9) 412 (401, 423) 0.143 (0.138, 0.149)
ECGP+RTE 1385 (629) 12.1 (11.7, 12.5) 273 (266, 279) 8.3 (8.1, 8.4) 462 (449, 475) 0.146 (0.137, 0.156)
ECGP+SUP 1754 (870) 14.6 (14.1, 15.2) 309 (303, 315) 7.9 (7.7, 8.1) 530 (514, 548) 0.131 (0.126, 0.135)
ECGP+RTE+SUP 1004 (486) 16.9 (16.2, 17.6) 329 (321, 337) 7.7 (7.5, 7.8) 547 (525, 570) 0.129 (0.123, 0.136)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Sex
Male
ECGP only 1755 (866) 8.9 (8.7, 9.2) 229 (225, 236) 9.4 (9.2, 9.7) 417 (405, 429) 0.145 (0.138, 0.152)
ECGP+RTE 713 (328) 11.6 (11.2, 12.1) 272 (266, 279) 9.1 (8.8, 9.4) 462 (443, 481) 0.151 (0.140, 0.163)
ECGP+SUP 807 (399) 13.9 (13.3, 14.6) 299 (291, 307) 8.6 (8.4, 8.8) 518 (500, 538) 0.134 (0.128, 0.139)
ECGP+RTE+SUP 466 (226) 16.1 (15.1, 17.2) 319 (309, 330) 8.2 (8.1, 8.4) 544 (518, 571) 0.126 (0.120, 0.132)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Female
ECGP only 1562 (787) 9.8 (9.5, 10.1) 239 (234, 245) 8.2 (8.0, 8.4) 408 (394, 423) 0.142 (0.136, 0.148)
ECGP+RTE 672 (301) 12.5 (12.0, 13.1) 272 (263, 281) 7.6 (7.3, 7.8) 458 (441, 477) 0.142 (0.133, 0.152)
ECGP+SUP 947 (471) 15.2 (14.6, 16.0) 318 (309, 327) 7.3 (7.2, 7.5) 540 (518, 565) 0.127 (0.121, 0.134)
ECGP+RTE+SUP 538 (260) 17.7 (16.9, 18.6) 338 (327, 350) 7.2 (6.9, 7.4) 550 (521, 581) 0.131 (0.122, 0.141)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 0.004
Age
19–39 y
ECGP only 1304 (636) 8.7 (8.5, 8.9) 216 (211, 222) 7.6 (7.5, 7.7) 419 (408, 430) 0.123 (0.117, 0.129)
ECGP+RTE 553 (231) 11.0 (10.5, 11.6) 250 (240, 260) 7.1 (6.9, 7.3) 481 (457, 508) 0.124 (0.113, 0.136)
ECGP+SUP 425 (194) 12.5 (11.8, 13.2) 272 (261, 282) 7.1 (6.9, 7.3) 518 (493, 546) 0.113 (0.107, 0.120)
ECGP+RTE+SUP 258 (115) 13.5 (12.8, 14.4) 282 (269, 297) 6.8 (6.6, 7.0) 502 (474, 531) 0.118 (0.109, 0.129)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 0.170
40–59 y
ECGP only 1090 (507) 9.2 (8.9, 9.6) 237 (232, 243) 8.7 (8.5, 8.9) 411 (397, 426) 0.142 (0.134, 0.150)
ECGP+RTE 354 (171) 11.7 (11.2, 12.2) 274 (263, 287) 8.2 (7.9, 8.5) 453 (434, 474) 0.141 (0.132, 0.150)
ECGP+SUP 611 (283) 14.3 (13.6, 15.0) 306 (296, 317) 8.0 (7.7, 8.3) 523 (497, 550) 0.130 (0.123, 0.138)
ECGP+RTE+SUP 239 (105) 16.7 (15.1, 18.3) 320 (317, 341) 7.8 (7.6, 8.0) 566 (528, 607) 0.129 (0.117, 0.142)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 0.048
60 y
ECGP only 943 (510) 10.6 (10.2, 11.0) 256 (247, 264) 11.1 (10.6, 11.5) 401 (384, 419) 0.187 (0.178, 0.195)
ECGP+RTE 478 (227) 14.7 (14.1, 15.3) 307 (299, 315) 10.5 (10.0, 11.0) 439 (409, 471) 0.208 (0.182, 0.238)
ECGP+SUP 718 (393) 18.9 (18.1, 19.7) 376 (364, 388) 9.4 (9.2, 9.6) 555 (536, 574) 0.164 (0.154, 0.175)
ECGP+RTE+SUP 507 (266) 22.5 (21.6, 23.5) 398 (384, 4141) 9.3 (8.9, 9.6) 567 (542, 593) 0.158 (0.148, 0.168)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Race-ethnicity
Non-Hispanic white
ECGP only 1396 (726) 9.6 (9.4, 9.9) 242 (236, 236) 9.0 (8.8, 9.2) 393 (384, 404) 0.152 (0.144, 0.159)
ECGP+RTE 726 (337) 12.6 (12.1, 13.1) 286 (278, 278) 8.5 (8.2, 8.7) 446 (432, 460) 0.157 (0.145, 0.169)
ECGP+SUP 1081 (555) 15.2 (14.6, 15.9) 322 (314, 330) 8.1 (7.9, 8.3) 519 (487, 517) 0.137 (0.131, 0.143)
ECGP+RTE+SUP 741 (369) 17.6 (16.7, 18.4) 342 (333, 351) 7.9 (7.7, 8.1) 531 (522, 576) 0.137 (0.129, 0.145)
P value4 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Non-Hispanic black
ECGP only 844 (386) 8.3 (8.1, 8.7) 196 (191, 201) 8.5 (8.3, 8.8) 484 (467, 501) 0.116 (0.109, 0.122)
ECGP+RTE 294 (125) 9.9 (9.5, 10.3) 215 (205, 225) 8.3 (8.0, 8.7) 524 (501, 549) 0.114 (0.103, 0.127)
ECGP+SUP 298 (132) 12.5 (11.9, 13.3) 255 (243, 267) 7.7 (7.4, 8.0) 582 (545, 620) 0.119 (0.111, 0.128)
ECGP+RTE+SUP 109 (40) 15.2 (13.7, 17.0) 280 (257, 305) 7.9 (7.5, 8.3) 647 (588, 712) 0.112 (0.104, 0.121)
P value4 ,0.001 ,0.001 0.001 ,0.001 0.768
Mexican American
ECGP only 837 (400) 8.8 (8.6, 9.1) 226 (219, 233) 7.4 (7.3, 7.5) 497 (466, 530) 0.113 (0.106, 0.120)
ECGP+RTE 286 (132) 10.7 (10.2, 11.3) 255 (244, 269) 7.1 (6.9, 7.3) 514 (486, 545) 0.107 (0.098, 0.117)
ECGP+SUP 251 (127) 13.3 (12.6, 14.0) 294 (280, 309) 7.0 (6.7, 7.2) 536 (506, 567) 0.117 (0.106, 0.130)
ECGP+RTE+SUP 114 (56) 13.5 (12.5, 14.6) 288 (270, 307) 6.6 (6.2, 6.9) 527 (469, 593) 0.115 (0.097, 0.137)
P value4 ,0.001 ,0.001 ,0.001 0.246 0.545
1 ECGP only, consumed enriched cereal-grain products only, excluding ready-to-eat cereals and supplements containing folic acid; ECGP+RTE, consumed enriched cereal-
grain products plus ready-to-eat cereals; ECGP+SUP, consumed enriched cereal-grain products (excluding ready-to-eat cereals) plus supplements containing folic acid; ECGP+RTE
+SUP, consumed enriched cereal-grain products, ready-to-eat cereals, and supplements containing folic acid.
2 Adjusted for age, sex, race-ethnicity, current smoking status, and BMI (calculated in weight in kilograms divided by height squared in meters) in multiple linear regression
models. Analyses were weighted and took into account the complex sampling design.
3 Unweighted n; unweighted n with methylmalonic acid measurements in the NHANES 2003–2004 in parentheses.
4 P values for testing differences in adjusted concentrations across different folic acid exposure groups based on Satterthwaite-adjusted F tests.
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vitamin B-12 intake from supplement labels may be an un-
derestimate (32). The sample size was inadequate in some
groups, which resulted in unstable estimates of prevalence of
excessive usual intakes. Nonresponse bias may result in an over-
or underestimate of the total folic acid intake among US adults;
however, estimates are weighted according to nonresponse.
Compared with the consumption of ECGP only, consumption of
RTE and/or supplements with folic acid is associated with higher
folate and vitamin B-12 intakes and concentrations among US
adults. Less than 3% of US adults exceeded the UL for folic acid in
2003–2006. Almost all of these adults consumed an average of
.400 lg folic acid/d from supplements. As recommended by the
Institute of Medicine, persons aged 51 y should consume the
required amount of vitamin B-12 from synthetic sources (7). Our
results and others (30) suggest that further investigation of the
average daily amount of synthetic vitamin B-12 required to pre-
vent deficiency among older adults is warranted.
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Erratum
Main PAE, Angley MT, Thomas P, O’Doherty CE, Fenech M. Folate and methionine metabolism in autism: a systematic
review. Am J Clin Nutr 2010;91:1598–620.
On page 1614, in the last paragraph of Results, the second and third sentences are as follows: ‘‘Although the largest study to
date found a significant association between RFC-1 80G/A and autism (OR: 2.13; 95% CI: 1.4, 3.4) (29), a subsequent study
failed to replicate the findings (37). On the other hand, an association was found between the 19-bp deletion of DHFR and
RFC-1 with autism (36).’’
These sentences should be replaced with the following: ‘‘The largest study to date found a significant association between
RFC-1 80G/A and autism (OR: 2.13; 95% CI: 1.4, 3.4) (29), but a smaller, inadequately powered study found no association
with this polymorphism (36).’’
doi: 10.3945/ajcn.2010.30167.
Erratum
Yang Q, Cogswell ME, Hamner HC, et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults:
National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am J Clin Nutr 2010;91:64–72.
In Table 2 on page 68, the median, 25th percentile, and 75th percentile values should be changed as follows: For adult males
who consumed ECGP1RTE1SUP, the median (interquartile range) usual folic acid intakes should be 653 (528, 801) lg/d, not
687 (552,849) lg/d. For adults aged 40–59 y who consumed ECGP only, the 75th percentile of usual vitamin B-12 intake
should be 6.9 lg/d, not 6.8 lg/d; and for all adults aged 40–49 y (‘‘Total’’), the 25th percentile of usual vitamin B-12 intake
should be 4.5 lg/d, not 4.2 lg/d. For non-Hispanic white adults who consumed ECGP1RTE1SUP, the 75th percentile of usual
folic acid intake should be 806 lg/d, not 896 lg/d. For non-Hispanic black adults who consumed ECGP1SUP, the 75th
percentile of usual vitamin B-12 intake should be 26.0 lg/d, not 23.8 lg/d. For Mexican American adults who consumed ECGP
only, the median and 25th percentile of usual folic acid intake should be 149 and 114 lg/d, respectively, not 114 and 149 lg/d.
The estimates were not adjusted for interview method. The footnote for Table 2 and for Supplemental Table 1 in the online
issue should therefore read ‘‘. . .were adjusted for participant ID, age, sex, race-ethnicity, and day of the week.’’ Similarly on
page 66, in the third paragraph under Statistical analyses, the first sentence should read, ‘‘In PC-SIDE, all analyses were
adjusted for age, sex, race-ethnicity, and day of the week.’’ These corrections do not change the interpretation of the results or
any of the results presented in the text.
doi: 10.3945/ajcn.2010.30166.
Erratum
George SM, Park Y, Leitzmann MF, et al. Fruit and vegetable intake and risk of cancer: a prospective cohort study. Am J Clin
Nutr 2009;89:347–53.
In Table 1 on page 349, a few values are incorrect. For ‘‘Fruit (cup equivalents/1000 kcal),’’ the value in the ‘‘Fruit/Men/Q5’’
column should be 2.1 instead of 1.4. For ‘‘Vegetable (cup equivalents/1000 kcal),’’ the values in the ‘‘Vegetable/Women/Q5,’’
‘‘Vegetable/Men/Q1,’’ and ‘‘Vegetable/Men/Q5’’ columns should be 1.8 instead of 1.4, 0.3 instead of 0.8, and 1.4 instead of 1.3,
respectively. In addition, in the right-hand column of page 351, the second sentence of the first full paragraph contains an error:
the second instance of ‘‘nonsmokers’’ should be ‘‘smokers’’ instead. The sentence should read as follows: ‘‘Also, in general,
nonsmokers had higher average median intakes of fruit and vegetables than did smokers.’’
doi: 10.3945/ajcn.2010.30168.
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